[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Monday, 27 March 2006, 09:48 GMT 10:48 UK
French drugs giant in Czech move
Sanofi-Aventis scientist at work
Sanofi-Aventis is the world's third largest drugmaker
French pharmaceutical giant Sanofi-Aventis has bought a 25% stake in Czech generic drugmaker Zentiva for 430m euros ($515m; 296m).

The move will strengthen Sanofi's presence in eastern Europe.

It bought the stake from private equity firm Warburg Pincus and several Zentiva managers and staff.

Zentiva has operations in Romania, the Czech Republic and Slovakia, and is expanding into Poland, Russia, and the Baltic states.

Geographical fit

The Czech firm made a 65m euros net profit last year on sales of 410m euros, and has more than 4,000 staff.

Strasbourg-based Sanofi-Aventis is the world's third largest drugmaker behind Pfizer and GlaxoSmithKline.

"The geographical reach is interesting, because it is still a developing market in which Zentiva has a very good position," said Bank Sal Oppenheim analyst Peter Duellmann.

"At some point in time it makes sense to be able to offer a bundling of products [combining branded and generic drugs] and to have a foot in the door to sell generic drugs."




SEE ALSO:
Aventis and Sanofi set for merger
26 Apr 04 |  Business
Aventis formally rejects Sanofi
17 Feb 04 |  Business
Aventis profits lead bid defence
05 Feb 04 |  Business
Bid to create French drug giant
26 Jan 04 |  Business


RELATED INTERNET LINKS:
The BBC is not responsible for the content of external internet sites



PRODUCTS AND SERVICES

Americas Africa Europe Middle East South Asia Asia Pacific